Cancer is a curse, but also a growth market for investors
Progress in developing treatments makes oncology research a favourite with investors
CANCER is a grim sort of growth market. By 2030 there will be over 22m new cases a year, up from 14m in 2012, according to the International Agency for Research on Cancer. But as the world marks World Cancer Day, on February 4th, scientists are speaking of a revolution in the battle to beat it. Money managers’ ears have pricked up. Oncology investing is “hot”.
This article appeared in the Finance & economics section of the print edition under the headline “Hunting for a cure”
Finance & economics
February 3rd 2018- “Factor investing” gains popularity
- The dollar keeps weakening. Is that good news for the world?
- Might higher interest rates spoil America’s economic boom?
- Cancer is a curse, but also a growth market for investors
- Cars block the road to a renegotiated NAFTA
- A safe asset is devised for the euro zone
- A big Blackstone deal shows how private equity has changed
- Zhou Xiaochuan, China’s central-bank chief, is about to retire
- Why sub-zero interest rates are neither unfair nor unnatural
From the February 3rd 2018 edition
Discover stories from this section and more in the list of contents
Explore the edition
Trump’s tariff turbulence is worse than anyone imagined
Even his concessions are less generous than expected
Why silver is the new gold
Safe-haven demand and solar panels have sent its price soaring
Trump’s new tariffs are his most extreme ever
America targets its three biggest trading partners: Canada, Mexico and China
El Salvador’s wild crypto experiment ends in failure
Its curtailment is the price of an IMF bail-out. And one worth paying
America is at risk of a Trumpian economic slowdown
Protectionist threats and erratic policies are combining to hurt growth
India has undermined a popular myth about development
Extreme poverty in the country has dropped to negligible levels